Navigation Links
China-Biotics, Inc. Files Application for Nasdaq Listing
Date:7/18/2008

SHANGHAI, China, July 18 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has applied for listing approval on the Nasdaq Global Market ("Nasdaq").

"This is an important milestone for China-Biotics, and we are committed to working with Nasdaq to fulfill all of its listing requirements," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "Nasdaq is a prestigious senior exchange that is well suited for high-technology and high-growth companies such as China-Biotics that meet its stringent listing requirements. Nasdaq's complement of small-cap, rapidly growing companies will increase our visibility among investors who follow companies like ours, improving trading volume and liquidity. This should, in turn, attract new investors to our Company."

China-Biotics believes it satisfies all of the listing qualifications associated with this application. The application is subject to review by Nasdaq's Listing Qualifications Department for compliance with all Nasdaq Global Market requirements. The Company's common stock will continue to trade on the OTC Bulletin Board under its current symbol, CHBT, until the Company is notified of its acceptance. We hope to receive approval to list on Nasdaq within two to three months.

About China-Biotics, Inc.

Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the Company") was founded in 1999 and is one of China's largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company's product portfolio contains live microbials made with proprietary technology. Currently, these products are sold over-the-counter under the "Shining" brand through large distr
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
2. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
3. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
4. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
5. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
6. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
7. China-Biotics, Inc. Completes Foundation for Its New Plant
8. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
9. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
10. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
11. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...., Nov. 6 Myriant Technologies LLC...and manufacturer of renewable bio-chemicals, Uhde...gy provider Uhde GmbH, one of the world,s leading ...d an alliance for the engineering, procurement &am...ic Acid plants based on renewable feedstocks. The...
(Date:11/6/2009)...if., Nov. 6 Intarcia Therapeutics,...A 650 (DUROS® continuous delivery of exenatid... the Ninth Annual Diabetes Technology Meeting in S....com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, C...TCA 650 Lowers Plasma Glucose, HbA1c and Reduces W...
(Date:11/5/2009)...N.J., Nov. 5 DSM Pharmaceutical Pr...uring alliance with Galenix, Saint Jean D,Illac, F...scale manufacturing partner for Galenix commercial... will collaborate on business development opportun...ies, based on the strength of Galenix in drug prod...
(Date:11/5/2009)...Y., Nov. 5 BioSpecifics ...utical company developing first-in-class collagena...esults for the third quarter ended September 30, 2...ember of this year, the FDA,s Arthritis Advisory C...0, the approval of XIAFLEX(TM) for the treatment o...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...Inc. , a rich media solutions company, today annou...30, 2003. During fiscal 2003, the company complete...off both its Media Services and Desktop Software d...b communications market. , ,Sonic Foundry finishe...with early stage business development efforts for ...
...he world in 1998, human embryonic stem cells were ...cine. The prospect of an unlimited supply of cells... public imagination and enthusiasm. , ,But lost in...ay of devastating and sometimes fatal diseases was...could match even the prospect of remaking transpla...
...lways on," Secure Solution For Mobile and Content ...om ) and Network365 announced today a joint initia...ution that helps generate additional revenue for m...es "always on," secure and trusted m-commerce tran...iders which then allows subscribers to use an expa...
Other Biology Technology:Sonic Foundry Reports Fiscal 2003 Results 2Stem Cells Illuminate Early Stages of Human Development 2Stem Cells Illuminate Early Stages of Human Development 3ADC and Network365 Team to Offer New End-to-End Mobile Payment System 2
(Date:11/4/2009)...mber 4, 2009 Childhood obesity in the United Stat...n one fourth of advertising on daytime and prime t...continuing questions about the role television pla...sue of the Journal of Nutrition Education and Beh...dren might be a large contributor to the problem. ...
(Date:11/4/2009)...atory that deciphered the DNA codes, or genomes, o...k, has joined The Genome 10K Project, an internati...NA sequences on 10,000 species of animals for cond...ly can not be achieved. , Participating in The G...in the Nov. 5, 2009 issue of the Journal of Hered...
(Date:11/4/2009)... Calif., Oct. 19 Spectros, develop...and imaging devices which shed light on life-threa...d exclusive distribution deals for both its T-Stat...ts covered include Australia, New Zealand, The Ne..., Italy, France, Spain, Portugal, Poland, Greece, ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2Spectros Signs New International Distribution Deals 2Allegiant Professional Business Services Inc Signs New Members to Its PPO Health Insurance Plan Annual Revenues Projected to Increase by 245M 50391 1Allegiant Professional Business Services Inc Signs New Members to Its PPO Health Insurance Plan Annual Revenues Projected to Increase by 245M 50391 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 1Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 3Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 4Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 5Biopure Receives Notice of Nasdaq Delisting 50386 1
...ided further evidence that environmental factors c...e studies, published online today (Thursday 28 Apr...nal Human Reproduction, suggest that environmental...arrying the X or Y (sex determining) chromosomes a...productive disorders. , A study by Swedish researc...
...multiple species within a community and are common...mission is often associated with pathogen emergenc...factor for humans, wildlife, and species of agricu...me disease or West Nile encephalitis that infect m... and their transmission rate is often thought to d...
...t and accurate imaging technique have shed light o...tle material within living cells. The motors coope...han engaging in the brute-force tug of war many sc...molecular motors -- dynein and kinesin -- do not c...the same cargo in opposite directions," said Paul ...
Other Biology News:How the environment could be damaging men's reproductive health 2How the environment could be damaging men's reproductive health 3How the environment could be damaging men's reproductive health 4A new study examines how shared pathogens affect host populations 2Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows 2
...nase profiling, quantitative measurement of kinase...uilt on the flexible and powerful Paraflo microflu... are available as part of our comprehensive Protei... Probe Content Our standard content PKS peptide ...
...ometer which offers high sensitivity, variable spe...0nm/min. Its horizontal beam optical design provi...sample volume requirements. It works with our FL ...which offers Excitation/Emission Scan, Time Based ...
...ized Advanced Pathogen Identification Device) is a...field hospitals, mobile laboratories and other rou... is designed with the same sensitivity and specify...e of thin-walled capillary tubes, the R.A.P.I.D. i...
...f two components used for alkaline phosphatase act...ic antibodies required to perform 100 tests (inclu...subject of extensive investigation recently, partl...hey raise several fundamental issues concerning th...
Biology Products: